Today: 6 March 2026
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Plug Power Stock (NASDAQ: PLUG) Today: Latest News, Analyst Forecasts, and Key Catalysts to Watch on Dec. 16, 2025

Plug Power Stock (NASDAQ: PLUG) Today: Latest News, Analyst Forecasts, and Key Catalysts to Watch on Dec. 16, 2025

Plug Power shares closed at $2.22 on Dec. 15, down 4.3%, with trading volume well below average. The stock remains volatile, trading between $0.69 and $4.58 over the past year. In November, Plug announced a $375 million private offering of 6.75% convertible notes due 2033, aiming to boost liquidity amid ongoing losses and market uncertainty.
16 December 2025
··
CoreWeave Stock Slide Sparks Fresh AI Bubble Fears as Debt, Data Center Delays, and Chip Depreciation Take Center Stage

CoreWeave Stock Slide Sparks Fresh AI Bubble Fears as Debt, Data Center Delays, and Chip Depreciation Take Center Stage

CoreWeave shares fell sharply December 16 after reports of construction delays at a major Texas data center tied to OpenAI. Investors cited concerns over the company’s heavy debt load and the economics of renting Nvidia GPUs as hardware ages and financing costs rise. Similar worries pressured Oracle and Broadcom this month amid scrutiny of AI infrastructure spending.
16 December 2025
······
Ondas Holdings Inc Stock (ONDS) Slides on Dec. 16, 2025 as Stifel Initiates Coverage, Investors Weigh Debt Exchange and Defense-Drone Growth

Ondas Holdings Inc Stock (ONDS) Slides on Dec. 16, 2025 as Stifel Initiates Coverage, Investors Weigh Debt Exchange and Defense-Drone Growth

Ondas Holdings shares fell about 12% to $7.69 on Tuesday after the company disclosed an exchange tied to its OAS unit that could add up to 7.33 million shares and trigger a one-time, non-cash charge of up to $60.5 million in Q4. The drop came despite Stifel initiating coverage with a Buy rating and a $13 price target. Trading volume spiked Monday, with over 40 million shares changing hands.
16 December 2025
··
NVIDIA Stock (NVDA) News and Forecasts for Dec. 16, 2025: Nemotron 3, SchedMD Deal, and China H200 Exports Take Center Stage

NVIDIA Stock (NVDA) News and Forecasts for Dec. 16, 2025: Nemotron 3, SchedMD Deal, and China H200 Exports Take Center Stage

Nvidia shares traded at $176.29 as of 11:45 UTC Tuesday, slightly above the previous close. The stock has been volatile in December amid competition concerns and shifts in U.S.-China chip export rules. Nvidia launched the Nemotron 3 open AI model family and acquired SchedMD, maker of the Slurm workload manager. U.S. policy now allows some Nvidia H200 chip exports to China under new restrictions.
16 December 2025
··
American Airlines Stock (AAL) News Today: S&P EETC Upgrade, UBS “Buy” Call, and Holiday Travel Catalyst in Focus (Dec. 16, 2025)

American Airlines Stock (AAL) News Today: S&P EETC Upgrade, UBS “Buy” Call, and Holiday Travel Catalyst in Focus (Dec. 16, 2025)

American Airlines shares closed Dec. 15 up 2.47% at $15.33, outperforming a weaker sector. S&P Global Ratings upgraded four of the airline’s aircraft-backed EETCs to ‘BBB+’ from ‘BBB’, citing improved loan-to-value ratios and resilient collateral values. Early Dec. 16 premarket trading showed AAL near $15.12 on high volume.
16 December 2025
·
Tesla Stock (TSLA) News Today: Robotaxi Tests Fuel Rally, But Wall Street Forecasts Split Wide on Dec. 16, 2025

Tesla Stock (TSLA) News Today: Robotaxi Tests Fuel Rally, But Wall Street Forecasts Split Wide on Dec. 16, 2025

Tesla traded at $475.31 as of 11:41 UTC on December 16, 2025, up 3.5% after CEO Elon Musk confirmed unsupervised robotaxi testing in Austin. Shares hit $481.37, the highest in nearly a year. Multiple autonomous Teslas were seen operating without safety monitors. Analysts cite autonomy milestones as fueling investor optimism despite ongoing scrutiny.
16 December 2025
··
Bristol-Myers Squibb (BMY) Stock Jumps on Analyst Upgrades, Dividend Hike, and a Catalyst-Rich 2026: What Investors Need to Know on Dec. 16, 2025

Bristol-Myers Squibb (BMY) Stock Jumps on Analyst Upgrades, Dividend Hike, and a Catalyst-Rich 2026: What Investors Need to Know on Dec. 16, 2025

Bristol-Myers Squibb shares rose 3.6% to $54.29 on December 16 after Bank of America upgraded the stock to Buy and raised its price target to $61, citing confidence in the company’s R&D pipeline. The board also increased the quarterly dividend to $0.63 per share, payable February 2, 2026, marking a 1.6% annual increase and the 17th consecutive yearly hike.
16 December 2025
···
Venus Concept Inc. (NASDAQ: VERO) Stock: Latest News, Catalysts, and Forecasts as of December 16, 2025

Venus Concept Inc. (NASDAQ: VERO) Stock: Latest News, Catalysts, and Forecasts as of December 16, 2025

Venus Concept shares fell 10.7% to $1.67 on Dec. 15, then rebounded pre-market to $2.16 amid heavy trading. The company secured amended loan agreements with Madryn, waiving liquidity requirements through year-end and allowing interest to be paid-in-kind. Venus NOVA received FDA 510(k) clearance for U.S. launch in December. Q3 results showed stabilization in devices but ongoing losses in the hair segment.
16 December 2025
·
Nektar Therapeutics Stock (NKTR) Surges Into a Major Catalyst: What to Know Ahead of Today’s REZOLVE-AA Data

Nektar Therapeutics Stock (NKTR) Surges Into a Major Catalyst: What to Know Ahead of Today’s REZOLVE-AA Data

Nektar Therapeutics shares rose 8%–11% in pre-market trading December 16 ahead of topline results from its Phase 2b REZOLVE-AA trial in severe-to-very-severe alopecia areata. The company will release data and hold an investor call at 8:00 a.m. ET. The trial enrolled about 90 patients and tested rezpegaldesleukin against placebo, with the primary endpoint at 36 weeks.
16 December 2025
··
SAVE Plan Shutdown: Student Loan Payments Could Restart for Millions—What Borrowers Need to Know (Dec. 16, 2025)

SAVE Plan Shutdown: Student Loan Payments Could Restart for Millions—What Borrowers Need to Know (Dec. 16, 2025)

The U.S. Department of Education has reached a proposed settlement to end the SAVE student loan repayment plan, halt new enrollments, and move current enrollees to other plans, pending court approval. Millions face a limited window to select new repayment options, but no timeline has been given. Many SAVE borrowers have not made payments in years due to pauses and forbearance.
16 December 2025
uniQure (QURE) Stock Jumps in Pre-Market on Dec. 16, 2025: FDA AMT-130 Uncertainty, Analyst Price Targets, and Key Catalysts Ahead

uniQure (QURE) Stock Jumps in Pre-Market on Dec. 16, 2025: FDA AMT-130 Uncertainty, Analyst Price Targets, and Key Catalysts Ahead

uniQure shares jumped about 15% to $23.50 in pre-market trading Dec. 16 after a 10% after-hours gain, despite ongoing FDA uncertainty over its Huntington’s disease gene therapy, AMT-130. The FDA told uniQure its Phase I/II data are “currently unlikely” to support a Biologics License Application, prompting the company to seek further talks in early 2026.
16 December 2025
··
Procter & Gamble Stock (PG) News Today: Price Rally Extends, Leadership Shifts, Dividend Outlook and Analyst Forecasts (December 16, 2025)

Procter & Gamble Stock (PG) News Today: Price Rally Extends, Leadership Shifts, Dividend Outlook and Analyst Forecasts (December 16, 2025)

Procter & Gamble shares closed up 1.6% at $145.13, marking a fifth straight daily gain despite broader market declines. Trading volume hit 12.9 million shares, well above average. The company disclosed Health Care division CEO Jennifer Davis will retire in June 2026. P&G remains about 19% below its March 52-week high.
16 December 2025
··
Affirm Holdings (AFRM) Stock News Today: CFO Fireside Chat, Analyst Targets, and BNPL Scrutiny in Focus (Dec. 16, 2025)

Affirm Holdings (AFRM) Stock News Today: CFO Fireside Chat, Analyst Targets, and BNPL Scrutiny in Focus (Dec. 16, 2025)

Affirm Holdings shares closed at $65.66 on Dec. 15, down 2.36%, ahead of a shareholder fireside chat with CFO Rob O’Hare scheduled for 9 a.m. Pacific. The event will use Say Technologies’ Q&A platform, allowing investors to submit and upvote questions on topics including unit economics and credit performance. Investors are watching for commentary after a quarter of strong growth and new merchant partnerships.
16 December 2025
·
Singapore Bank Stocks Hit Record Highs on Dec 16, 2025: DBS and OCBC Surge, UOB Lags as Investors Eye Dividends and 2026 Momentum

Singapore Bank Stocks Hit Record Highs on Dec 16, 2025: DBS and OCBC Surge, UOB Lags as Investors Eye Dividends and 2026 Momentum

DBS and OCBC hit record highs in Singapore trading Tuesday, with DBS reaching S$56 and OCBC S$19.44. UOB lagged at S$34.79, down over 4% for the year. DBS was named Singapore’s second offshore renminbi clearing bank, as Singapore and China launched a digital RMB pilot for travelers. The broader Singapore market closed slightly lower.
16 December 2025
···
Tesla Stock (TSLA) Surges on Driverless Robotaxi Tests: Latest News, Analyst Forecasts, and Key Risks for December 16, 2025

Tesla Stock (TSLA) Surges on Driverless Robotaxi Tests: Latest News, Analyst Forecasts, and Key Risks for December 16, 2025

Tesla shares rose to around $475 on December 16 after CEO Elon Musk confirmed the company is testing robotaxis in Austin without in-car safety monitors. The stock traded near a one-year high, up about 3.5%. Videos showed autonomous Teslas operating publicly, fueling debate among analysts over the company’s valuation. Waymo, a key rival, has already logged over 14 million paid robotaxi rides this year.
16 December 2025
···
Immunome (IMNM) Stock Today: Phase 3 RINGSIDE Win, $400M Offering, and Fresh Analyst Targets (Dec. 16, 2025)

Immunome (IMNM) Stock Today: Phase 3 RINGSIDE Win, $400M Offering, and Fresh Analyst Targets (Dec. 16, 2025)

Immunome reported positive Phase 3 results for varegacestat in desmoid tumors, showing an 84% reduction in risk of progression or death versus placebo. The company also announced a proposed $400 million stock offering, raising concerns about dilution. Most side effects were mild, but 55.6% of premenopausal women experienced ovarian toxicity. Shares moved sharply on the news.
16 December 2025
··
1 … 441 442 443 444 445 … 584
Go toTop